Faron Pharmaceuticals Oy (FARN) — Net Asset Quality Index
Faron Pharmaceuticals Oy (FARN) has a Net Asset Quality Index of -100.3% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX16.20 Million minus total liabilities of GBX32.45 Million yields net assets of GBX-16.25 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check FARN asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Faron Pharmaceuticals Oy Net Asset Quality Index Over Time (2012–2024)
This chart shows how Faron Pharmaceuticals Oy's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of June 2025, the index stands at -100.3%, representing net assets of GBX-16.25 Million against total assets of GBX16.20 Million GBX. See working capital to net assets of Faron Pharmaceuticals Oy to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Faron Pharmaceuticals Oy (2012–2024)
The table below presents the year-by-year Net Asset Quality Index for Faron Pharmaceuticals Oy from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Faron Pharmaceuticals Oy market cap and net worth.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -78.0% | GBX-9.76 Million | GBX12.52 Million | GBX22.28 Million | ▲ +70.4 pp |
| 2023 | -148.3% | GBX-15.16 Million | GBX10.22 Million | GBX25.38 Million | ▼ -46.5 pp |
| 2022 | -101.8% | GBX-11.48 Million | GBX11.27 Million | GBX22.75 Million | ▼ -124.0 pp |
| 2021 | 22.1% | GBX2.92 Million | GBX13.18 Million | GBX10.26 Million | ▲ +44.2 pp |
| 2020 | -22.1% | GBX-1.85 Million | GBX8.37 Million | GBX10.22 Million | ▼ -37.9 pp |
| 2019 | 15.8% | GBX1.61 Million | GBX10.21 Million | GBX8.60 Million | ▲ +11.2 pp |
| 2018 | 4.6% | GBX369.00K | GBX8.00 Million | GBX7.63 Million | ▼ -27.2 pp |
| 2017 | 31.9% | GBX4.74 Million | GBX14.89 Million | GBX10.14 Million | ▼ -31.1 pp |
| 2016 | 63.0% | GBX10.88 Million | GBX17.29 Million | GBX6.40 Million | ▼ -12.5 pp |
| 2015 | 75.4% | GBX11.18 Million | GBX14.82 Million | GBX3.64 Million | ▲ +130.3 pp |
| 2014 | -54.9% | GBX-1.19 Million | GBX2.17 Million | GBX3.35 Million | ▼ -12.5 pp |
| 2013 | -42.4% | GBX-949.00K | GBX2.24 Million | GBX3.19 Million | ▲ +0.8 pp |
| 2012 | -43.2% | GBX-837.00K | GBX1.94 Million | GBX2.77 Million | — |